Search for:

  
About NPCIn the NewsResources and PublicationsNewsroomQuestions & Answers


Contact Us 
Receive Updates 
Links 
Home 

Resources & Publications

By Title
(Alphabetical)


By Audience

By Disease

By Specific Issue Areas

Request NPC Publications

New Publication Notification

Permissions Request

Resources & Publications

The National Pharmaceutical Council offers a wide variety of printed and electronic resources. Many are available in hard copy, on CD-ROM, and as downloadable PDF files.

Hard copies and CD-ROMs are free of charge in small quantities, unless otherwise noted on the request form. For bulk or rush orders, you may be asked to pay some printing and/or shipping costs. You will be contacted if a charge applies to your order.

Free-access PDFs have been provided whenever possible, however some journals charge a fee for non-subscribers to access articles on their Web sites. If you are not a journal subscriber, you may choose to purchase the article directly through the journal's Web site. NPC does not act as an intermediary for such transactions.

New from NPC!

NICE: How does it work and what are the implications for the U.S.?

Executive Summary (April 2008)

Full report (April 2008)

This 4-part project examines the National Institute for Health and Clinical Excellence (NICE) and its operations, and the implications for comparative effectiveness reviews in the U.S.

  • Phase 1* entails a non-technical overview of NICE, encompassing its governance and organization, topic selection procedures, evidence requirements and assessment methods, and guidance dissemination and implementation.
  • Phase 2* provides an in-depth investigation of evidence requirements and assessment methods.
  • Phase 3* involves an analysis of public comments on NICE submitted to the House of Commons Health Select Committee, focusing on key stakeholder perspectives on the appraisal process and broader NICE operations.
  • Phase 4* examines NICE procedures and standards in the context of the U.S. landscape, and identifies those factors or forces unique to the U.S. marketplace, in comparison to the U.K. and other EU Member States, where applicable.

Improving and Measuring Osteoporosis Management
(March 2008)


In the U.S., an estimated 10 million people are living with osteoporosis, also called brittle bone disease. Although osteoporosis is responsible for the majority of hip fractures, and accounts for more than eighteen billion dollars in health care expenditures annually, on average only 20% of patients are ever screened or treated for the disease. A new monograph developed by The Joint Commission through an unrestricted educational grant by NPC, contains 10 voluntary measures of care, designed for a variety of healthcare settings. Intended for a professional audience, the monograph contains clinical information and practical tips for implementing an osteoporosis improvement initiative, whether clinical care is given in a hospital, emergency department, rehabilitation facility, home health agency, or doctor's office.